Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Desert Control releases its Q3 2022 Report and Year-to-Date Company Update

ISSUER DESERT CONTROL AS Sandnes, Norway, 25 November 2022 – Desert Control AS (DSRT) announces its thirdquarter report and interim financial results for the fiscal period ending 30September 2022 and shares its year-to-date company update per 25 November 2022.Desert Control secures the first commercial contract in the United States,increases efficiency with lower operational costs in the UAE, and enters MoU forfuture projects in Southern Europe. The company closes the third quarter with apositive cash balance of NOK 100 Million and has no interest-bearing debt.Q3 and

The REWAISE project: Collaboration and innovation in Spain

At Aquaporin, we focus on providing the best service and experience when we collaborate with a partner. Therefore, Aquaporin also spends time visiting ongoing projects. This approach to business sent Aquaporin employees Jan Benecke, Head of Commercial Engineering Reverse Osmosis, and Hanh Le, Membrane Applications Engineer, from Lyngby, Denmark, to two waterworks in Berja and Denia, Spain. During their one-week visit to Spain, the two Aquaporin employees looked closely at two unique projects. In Berja, Aquaporin is part of the REWAISE project managed by FCC Aqualia. Jan Benecke and Hanh

Norse Atlantic ASA: Successful completion of private placement

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Arendal, 25 November 2022: Reference is made to the stock exchange notice from Norse Atlantic ASA ("Norse" or the "Company") published on 24 November 2022 regarding a contemplated fully underwritten private placement of 120,000,000 new ordinary shares

Nordea Bank Abp: Repurchase of own shares on 24.11.2022

Nordea Bank AbpStock exchange release – Changes in company’s own shares24.11.2022 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 24.11.2022 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading Number Weighted average Total cost, EUR* **venue (MIC of price / share, EUR* Code) shares **XHEL 139,433 10.10 1,408,928.64CEUX 141,379 10.12 1,430,966.75TQEX 20,110 10.13  203,714.00XSTO 132,872 10.14  1,346,898.24

OXE MARINE AB (PUBL) CONVENING NOTICE FOR EXTRAORDINARY GENERAL MEETING

On 20 November 2022, the board of directors of OXE Marine AB (publ) (the “Company”) resolved to raise SEK 70 m by way of a directed share issue of in total 49,122,807 new shares. Out of the total amount, SEK 68.575 m, corresponding to 48,122,807 new shares, was resolved by the board under the mandate from the annual general meeting and was directed to a group of existing and new investors. The remaining amount of SEK 1.425 m, corresponding to 1,000,000 shares, was directed to Alpraaz AB, a company owned by board member Christian von Koenigsegg, and was therefore resolved by the board

ODI Pharma AB postpones publication of interim report and annual report until November 25, 2022

ODI Pharma AB (“ODI” or the “Company”) stated in its year-end report that the interim report for the first quarter of 2022/2023 and the annual report for the fiscal year 2021/2022 would be published on November 24, 2022. Instead, the interim report and the annual report will be published on November 25, 2022, three weeks before the Annual General Meeting on December 16, 2022.For more information, please contact: Derek Simmross, CEO, ODI Pharma AB E-mail: info@odipharma.com   ODI Pharma AB ODI Pharma, based on its European network, subsidiaries and affiliates, is a producer and

Intrum – Further negative adjustments of c. SEK 4.3 bn in the Italian SPV following sale of co-investor exposure to Kistefos Investment AS (“Kistefos”)

Funds managed by AB CarVal Investors, L.P (“AB CarVal”) have agreed to sell their 37.5% exposure in the jointly managed Italian SPV (“SPV”), which owns the portfolio that Intrum, together with partners, acquired in 2018, to Kistefos for a consideration of SEK 109 M. In the context of the transaction Intrum AB (publ) (“Intrum”) has entered into a new joint control co-investment agreement with Kistefos and has settled a derivative agreement with AB Carval.As this is an arm’s length transaction between unrelated parties and therefore objective evidence, Intrum will reflect this valuation in

OPINION: 1.5°C is not a target, it’s a limit and to reach that we need action – now

Jesper Brodin, CEO of Ingka Group shares his views on Ingka Group’s recent participation at COP27, United Nations Climate Change Conference and the importance of keeping 1.5°C alive and deliver to the Paris Agreement.Taking part in COP27* was an important opportunity for me and us as a company to share what we do, as well as get inspired and connect with other businesses, governments, NGO’s and young leaders. Climate change is not a distant threat, rather a living reality that impacts us all, in ways we could never imagine. My commitment as CEO of Ingka Group, to sustainability and climate

Read original

Intervacc’s Chief Scientific Officer Dr Andrew Waller participate at the Dutch Equine Conference

Stockholm, November 24, 2022 - The Dutch Equine Conference is one of the Benelux region equine veterinary profession’s events, and it is back again this year! Intervacc’s Chief Scientific Officer Dr Andrew Waller will participate in two sessions about the prevention of equine strangles on Friday the 25th of November at 13:40 pm and at 16.20 pm. “It’s a fantastic opportunity to speak about equine strangles directly to equine professionals at the Dutch Equine Conference. There are new and important tools in the preventative work against this terrible disease that causes much suffering

ALEXANDRIA PANKKIIRILIIKE OYJ: ACQUISITION OF OWN SHARES 24.11.2022

ALEXANDRIA PANKKIIRILIIKE OYJ NOTIFICATION    24.11.2022 at 18:30 EET   ALEXANDRIA PANKKIIRILIIKE OYJ: ACQUISITION OF OWN SHARES 24.11.2022   Date 24.11.2022  Exchange transaction Buy  Share class ALEX  Amount 15  Average price/share 6.7400 EURHighest price/share 6.7400 EURLowest price/share 6.7400 EURTotal price 101.10 EUR        The shares held by Alexandria Pankkiiriliike Oyj on 24.11.

Multiconsult ASA - Share buyback

Multiconsult ASA (OSE: MULTI) announced on 19. September 2022 a non-discretionary agreement with ABG Sundal Collier for the repurchase of up to 500,000 of its ordinary shares in the market in connection with its employee share purchase programme in 2022.From 16. november 2022 until 24. November 2022, Multiconsult ASA has purchased a total of 20,744 own shares at Oslo Børs at an average price of NOK 131.2247 per share. Aggregated overview of transactions per day: Overview oftransactionsDate Aggregated daily Weighted average Total daily volume (number

Atea ASA - share buyback

Oslo, 24 November Please see below information about transactions made under the share buyback programme for Atea ASA. Date on which the buyback programme was announced: 24 October 2022 The duration of the buyback programme: 26 October 2022 to 31 December 2022, or until the maximum number of shares has been repurchased. Size of the buyback programme: Up to 800,000 shares From 18 November 2022 until 24 November 2022, Atea ASA has purchased a total of 87,500 own shares at the Oslo Stock Exchange at an average price of NOK 120.98 per share. Following the completion of the above

CESSATECH’S BOARD RESOLVES ON COMPENSATION ISSUE IN CONNECTION WITH THE RECENT RIGHTS ISSUE

København, Denmark, November 24, 2022 – At a board meeting today the board of directors in Cessatech A/S (“Cessatech” or the “Company”) resolved on the issue of additional units (“Compensation Units”) to guarantee underwriters in the Company’s recent rights issue. A total of 56,875 Compensation Units each consisting of 6 new shares and 3 warrants of series TO2 will be issued to certain investors in respect of their underwriting commitments. Cessatech’s nominal share capital following the issue will increase to DKK 2,757,751 equal to 13,788,755 issued shares of DKK 0.2 each.As described in

Share buy back

Oslo, 24 November 2022 Hunter Group ASA (the "Company") has today purchased 3,450,000 of its own shares at an average price of NOK 2.169 per share. The Company now owns a total of 8,212,826 of its own shares. Contact: Erik A.S. Frydendal, CEO, ef@huntergroup.no, Ph.: +47 957 72 947 Lars M. Brynildsrud, CFO, lb@huntergroup.no, Ph.: +47 932 60 882 This information is subject to the disclosure requirements in section 5-12 of the Norwegian Securities Trading Act.

Norse Atlantic ASA: Contemplated fully underwritten private placement

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Arendal, 24 November 2022: Norse Atlantic ASA ("Norse" or the "Company") has engaged Pareto Securities AS and SpareBank 1 Markets AS as joint bookrunners (jointly the "Managers") to advise on and effect a contemplated underwritten private placement of

#22-400 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

#22-399 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

Information about Attana’s presentation at Stora Aktiedagen on November 29

On Tuesday, November 29 at 8.30 pm, Attana will attend Stora Aktiedagen where Teodor, CEO of Attana, will hold a 20-minute company presentation followed by a 10-minute Q&A session.The main purpose of the presentation is to present Attana´s two business areas, Life Science and Diagnostics, and the most recent progress made in each area. Information regarding Attana´s upcoming rights issue with a subscription period running December 14–29 will also be presented. Content: 1. Attana in short  2. Attana Life Science  3. Attana Diagnostics  4. Rights issue 2023 The event

TOMRA: Mandatory notification of trade

Bjørn Matre, represented at TOMRA System ASA's board of directors, has today sold 7,900 shares in TOMRA Systems ASA at a price of NOK 190.17 per share through his wholly owned company Lille Oslo Eiendom AS. After the acquisition Bjørn Matre holds 5,192 shares in TOMRA Systems ASA. Bjørn Matre has previously purchased 2,860 shares in TOMRA Systems ASA on 3 May 2022, at a price of NOK 354.85 per share through his wholly owned company Lille Oslo Eiendom AS. As a result of a misunderstanding, the notification of the transaction is only issued today. An overview of transactions is provided

AcouSort presents at Stora Aktiedagen in Stockholm, November 30, addressing current developments in the vibrant cell therapy space

On November 30, 2022, CEO Torsten Freltoft will present at Stora Aktiedagen in Stockholm. In his presentation, Torsten will talk about the company's continuous advancements in the cell therapy space, an area with potential to have a huge impact on future medical treatments. The company recently entered a collaboration with a global life science company active in the cell therapy field.AcouSort invites journalists, analysts, and shareholders to take part in the live broadcast at www.aktiespararna.se/tv/live. No registration is required to follow the event digitally. You can also use this

ADDvise receives order worth USD 1.7 million

ADDvise Group AB’s subsidiary MRC Systems FZE has received an order from BioGeneric Pharma, a leading factory in biotechnology based in Cairo, Egypt. The order is worth approximately USD 1.7 million. The order is an add-on-project in the ongoing project between the parties regarding design, supply, and commissioning of clean room environment to be used for production of mRNA-vaccine. BioGeneric Pharma has been selected by the World Health Organization (WHO) to be the first technology transfer recipient of mRNA-vaccine hub in Egypt for distribution in Africa. Delivery of the order is planned

SOFTSWISS Recognised as Workplace of the Year 2022

SOFTSWISS, an innovative software developing company, was recognised as Workplace of the Year at the SiGMA Europe Awards. The company has added this new trophy to the list of its winnings during one of the most significant industry events on the continent, SiGMA Europe 2022.As one of the leading figures in iGaming, SOFTSWISS  sets a high value on  its people, their development and well-being and makes every possible effort to create a supportive work environment. Being recognised as the

Spinomenal Celebrates Black Friday With Book of Piggy Bank – Riches Launch

Spinomenal , the leading iGaming content provider, is celebrating Black Friday with the release of its exciting new game, Book of Piggy Bank – Riches. The game sits within the Classics series which exists within the Spinomenal Universe.No one likes to save money, but everyone loves to break piggy banks! Spinomenal’s brand new game is a 6x3 reel design with 10 pay lines that gives players the opportunity to raid the Piggy’s bank of riches! This vibrant, money themed slot game takes you on a treasure hunt for cash and luxury with plenty of excitement and suspense

There are no items matching the current filter
There are no more items matching the current filter
Back to top